1
|
Manuylov V, Burgasova O, Borisova O, Smetanina S, Vasina D, Grigoriev I, Kudryashova A, Semashko M, Cherepovich B, Kharchenko O, Kleymenov D, Mazunina E, Tkachuk A, Gushchin V. Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection. Viruses 2022; 14:v14030617. [PMID: 35337024 PMCID: PMC8949074 DOI: 10.3390/v14030617] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2022] [Revised: 03/07/2022] [Accepted: 03/12/2022] [Indexed: 12/19/2022] Open
Abstract
The avidity index (AI) of IgG to the RBD of SARS-CoV-2 was determined for 71 patients with a mild (outpatient) course of COVID-19, including 39 primarily and 36 secondarily reinfected, and 92 patients with a severe (hospital) course of COVID-19, including 82 primarily and 10 secondarily infected. The AI was shown to correlate with the severity of repeated disease. In the group of outpatients with a mild course, the reinfected patients had significantly higher median AIs than those with primary infections (82.3% vs. 37.1%, p < 0.0001). At the same time, in patients with a severe course of COVID-19, reinfected patients still had low-avidity antibodies (median AI of 28.4% vs. 25% in the primarily infected, difference not significant, p > 0.05). This suggests that the presence of low-avidity IgG to RBD during reinfection is a negative prognostic factor, in which a patient’s risk of developing COVID-19 in a severe form is significantly increased. Thus, patients with IgG of low avidity (AI ≤ 40%) had an 89 ± 20.5% chance of a severe course of recurrent COVID-19, whereas the detection of high-avidity antibodies (AI ≥ 50%) gave a probability of 94 ± 7.9% for a mild course of recurrent disease (p < 0.05).
Collapse
Affiliation(s)
- Victor Manuylov
- Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia; (O.B.); (D.V.); (I.G.); (M.S.); (D.K.); (E.M.); (A.T.); (V.G.)
- MedipalTech LLC, 141981 Dubna, Russia
- Correspondence: ; Tel.: +7-968-4040-955
| | - Olga Burgasova
- Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia; (O.B.); (D.V.); (I.G.); (M.S.); (D.K.); (E.M.); (A.T.); (V.G.)
- Medical Institute, Peoples Friendship University of Russia (RUDN University), 117198 Moscow, Russia
| | - Olga Borisova
- Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia; (O.B.); (A.K.); (B.C.); (O.K.)
| | | | - Daria Vasina
- Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia; (O.B.); (D.V.); (I.G.); (M.S.); (D.K.); (E.M.); (A.T.); (V.G.)
| | - Igor Grigoriev
- Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia; (O.B.); (D.V.); (I.G.); (M.S.); (D.K.); (E.M.); (A.T.); (V.G.)
| | - Alexandra Kudryashova
- Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia; (O.B.); (A.K.); (B.C.); (O.K.)
| | - Maria Semashko
- Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia; (O.B.); (D.V.); (I.G.); (M.S.); (D.K.); (E.M.); (A.T.); (V.G.)
| | - Bogdan Cherepovich
- Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia; (O.B.); (A.K.); (B.C.); (O.K.)
| | - Olga Kharchenko
- Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia; (O.B.); (A.K.); (B.C.); (O.K.)
| | - Denis Kleymenov
- Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia; (O.B.); (D.V.); (I.G.); (M.S.); (D.K.); (E.M.); (A.T.); (V.G.)
| | - Elena Mazunina
- Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia; (O.B.); (D.V.); (I.G.); (M.S.); (D.K.); (E.M.); (A.T.); (V.G.)
| | - Artem Tkachuk
- Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia; (O.B.); (D.V.); (I.G.); (M.S.); (D.K.); (E.M.); (A.T.); (V.G.)
| | - Vladimir Gushchin
- Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia; (O.B.); (D.V.); (I.G.); (M.S.); (D.K.); (E.M.); (A.T.); (V.G.)
| |
Collapse
|